Surgical Treatment of Recurrent Colorectal Cancer.
- Author:
Gwang Mo KOO
1
;
Sang Su PARK
;
Jin YOON
;
Il Myoung KIM
;
Byoung Uk YU
;
Dae Hyun YANG
;
Ik Hang CHO
Author Information
1. Department of Surgery, Kangnam General Hospital Public Corporation, Korea. gspss@kangnamhosp.or.kr
- Publication Type:Original Article
- Keywords:
Colorectal Neoplasm, Survival rate, Neoplasm recurrent, Local
- MeSH:
Colon;
Colorectal Neoplasms*;
Humans;
Liver;
Neoplasm Metastasis;
Rectum;
Recurrence;
Retrospective Studies;
Survival Rate
- From:Journal of the Korean Society of Coloproctology
2003;19(5):314-321
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Recurrent colorectal cancers have important and difficult diagnostic and treatment problems. The purpose of this study is to evaluate the rationale and the efficacy of surgical re-treatment for patients with recurrence following curative surgery for colorectal cancer. METHODS: From January 1991 to December 2002, we experienced 60 (20.9%) patients with recurred colorectal cancer among 287 patients who had curative operations in our hospital. These 60 patients were divided into three groups. Patients in group 1 had curative-intent resections, patients in group 2 had palliative resections, and patients in group 3 had conservertive treatment. The groups consisted of 17 (28.3%), 10 (16.7%) and 33 (55.0%) patients, respectively. We analyzed retrospectively those groups for any recurrence pattern and for survival. RESULTS: Of the 60 patients with recurrent colorectal cancer, in 20 (33.3%) patients the cancer recurred in the colon, and in 40 (66.7%) it recurred in the rectum. Local recurrence was seen in 9 (15.0%) patients, liver metastasis in 25 (41.7%), and pulmonary metastasis in 13 (21.7%). The 1- and 3-, and 5-year survival rates were 86.5%, 31.7%, and 15.9%, respectively, for group 1, 33.3%, 0%, and 0% for group 2, and 28.9%, 4.4%, and 4.4% for group 3. The median survival period was 31 months for group 1, 8 months for group 2, and 7 months for group 3. CONCLUSIONS: Although evaluation was difficult owing to the small number of patients with recurrent colorectal cancer, a significant difference in survival rates was observed between the treatment groups. On the basis of these results, we think that curative-intent aggressive surgery for recurrent colorectal cancer in appropriately selected cases can clearly prolong survival when compared with palliative resections and conservative treatment.
